MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)
Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem Highlights MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts communityExclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSEMMA.INC to participate directly in revenue generated across its global customer baseP